SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
vco12094-sup-0001-TableS1.docWord document35KTable S1. CI values for OS 2.4 cell line dual treatment with doxorubicin and tepoxalin. 0–0.8 indicates synergy; 0.81–1.2 indicated additive or neutral effects; >1.21 indicates antagonism between the treatments.
vco12094-sup-0002-TableS2.docWord document39KTable S2. CI values for HMPOS cell line dual treatment with doxorubicin and tepoxalin. 0–0.8 indicates synergy; 0.81–1.2 indicated additive or neutral effects; >1.21 indicates antagonism between the treatments.
vco12094-sup-0003-TableS3.docWord document35KTable S3. CI values for D17 cell line dual treatment with doxorubicin and tepoxalin. 0–0.8 indicates synergy; 0.81–1.2 indicated additive or neutral effects; >1.21 indicates antagonism between the treatments.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.